Former UFC heavyweight Konstantin Erokhin received a one-year suspension at a Wednesday hearing of the Nevada Athletic Commission as a result of a failed drug test for the anabolic steroid drostanolone at The Ultimate Fighter 22 Finale on Dec. 11 in Las Vegas, NV.
Erokhin (9-3) tested positive for the banned substance in a pre-fight, in-competition test ahead of a sluggish unanimous decision loss against Gabriel Gonzaga. The drug screening was administered by Quest Diagnostics at the behest of the NAC, rather than USADA. The UFC released Erokhin following the loss.
Erokhin, 34, was a no-show at Wednesday's hearing.
In addition to the suspension, the Russian heavyweight was also fined 33-percent of his $10,000 fight purse ($3,300) and will be required to pass a drug test before being relicensed in the state of Nevada.
The one-year suspension is retroactive to Dec. 11, 2015.
Erokhin lost both of his fights under the UFC umbrella, falling short in decisions against Viktor Pesta and Gonzaga. Prior his Octagon run, Erokhin racked up nine straight wins, highlighted by knockouts of Rameau Thierry Sokoudjou and Dave Huckaba, as well as a decision over Brett Rogers.